The science behind banning desflurane: A narrative review
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
The science behind banning desflurane : A narrative review. / Hendrickx, Jan F. A.; Nielsen, Ole John; De Hert, Stefan; De Wolf, Andre M.
I: European Journal of Anaesthesiology, Bind 39, Nr. 10, 10.2022, s. 818-824.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The science behind banning desflurane
T2 - A narrative review
AU - Hendrickx, Jan F. A.
AU - Nielsen, Ole John
AU - De Hert, Stefan
AU - De Wolf, Andre M.
PY - 2022/10
Y1 - 2022/10
N2 - Potent inhaled anaesthetics are halogenated hydrocarbons with a large global warming effect. The use of fluorinated hydrocarbons (most are not anaesthetics) are being restricted but volatile anaesthetics have been exempted from legislation, until now: the EU has formulated a proposal to ban or at least severely restrict the use of desflurane starting January 2026. This narrative review addresses the implications of a politics-driven decision - without prior consultation with major stakeholders, such as the European Society of Anaesthesiology and Intensive Care (ESAIC) - on daily anaesthesia practice and reviews the potential scientific arguments that would support stopping the routine use of desflurane in anaesthetic practice. Of note, banning or severely restricting the use of one anaesthetic agent should not distract the user from sensible interventions like reducing fresh gas flows and developing technology to capture and recycle or destroy the wasted potent inhaled anaesthetics that we will continue to use. We call to join efforts to minimise our professional environmental footprint.
AB - Potent inhaled anaesthetics are halogenated hydrocarbons with a large global warming effect. The use of fluorinated hydrocarbons (most are not anaesthetics) are being restricted but volatile anaesthetics have been exempted from legislation, until now: the EU has formulated a proposal to ban or at least severely restrict the use of desflurane starting January 2026. This narrative review addresses the implications of a politics-driven decision - without prior consultation with major stakeholders, such as the European Society of Anaesthesiology and Intensive Care (ESAIC) - on daily anaesthesia practice and reviews the potential scientific arguments that would support stopping the routine use of desflurane in anaesthetic practice. Of note, banning or severely restricting the use of one anaesthetic agent should not distract the user from sensible interventions like reducing fresh gas flows and developing technology to capture and recycle or destroy the wasted potent inhaled anaesthetics that we will continue to use. We call to join efforts to minimise our professional environmental footprint.
KW - MORBIDLY OBESE-PATIENTS
KW - SEVOFLURANE
KW - RECOVERY
KW - ANESTHESIA
KW - ISOFLURANE
KW - CLIMATE
U2 - 10.1097/EJA.0000000000001739
DO - 10.1097/EJA.0000000000001739
M3 - Review
C2 - 36036420
VL - 39
SP - 818
EP - 824
JO - European Journal of Anaesthesiology, Supplement
JF - European Journal of Anaesthesiology, Supplement
SN - 0952-1941
IS - 10
ER -
ID: 320008427